Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support - Takeaways - MDSpire

Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support

  • By

  • Duc M. Giao

  • Adham Makarem

  • Ameen M. Basha

  • Chijioke Chukwudi

  • Ruby Singh

  • Boateng Kubi

  • George E. Olverson

  • Thais Faggion Vinholo

  • Aabha Divya

  • Kamila Drezek

  • David A. D’Alessandro

  • Eriberto Michel

  • Asishana A. Osho

  • May 21, 2026

  • 0 min

Share

  • 1

    The study involved 16 patients undergoing isolated CABG with Impella 5.5 support, highlighting its feasibility in severe LV dysfunction cases.

  • 2

    Eighty-one percent of patients were successfully weaned from Impella support, with one patient bridged to durable LVAD therapy.

  • 3

    The overall in-hospital mortality rate was 18.8%, indicating acceptable short-term outcomes for high-risk CABG patients.

  • 4

    Rhythm complications were common, occurring in 56.3% of patients, but were generally manageable without major bleeding or access-site infections.

  • 5

    Impella 5.5 support may serve as a valuable adjunct to surgical revascularization in carefully selected high-risk CABG patients.

Original Source(s)

Outcomes following coronary artery bypass grafting with temporary left ventricular assist device support

  • by Duc M. Giao, Adham Makarem, Ameen M. Basha, Chijioke Chukwudi, Ruby Singh, Boateng Kubi, George E. Olverson, Thais Faggion Vinholo, Aabha Divya, Kamila Drezek, David A. D’Alessandro, Eriberto Michel, Asishana A. Osho

  • May 21, 2026

Related Content

The Impact of Right Ventricular Function on Left Ventricular Mechanical Circulatory Support

Extended Ex-Situ Heart Perfusion Maintains Cardiac Function After Orthotopic Transplantation in a Pig Model

Case Report: Giant myxosarcoma involving both atria